VistaGen Therapeutics (VTGN)

• Market cap: $20M
• 1 day: -7.23%
• 5 days: -4.6%
• 1 month: -26.25%
• 3 months: -86.69%
• 6 months: -82.74%
• Year to date: -25.54%
• 1 year: -82.26%
• 5 years: -99.15%
• 10 years: -99.59%
• Sector: Healthcare
• Industry: Biotechnology

About: Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Employees: 59